To access its particular impact on atherosclerosis, Ldlr−/− mice fed with a high-fat diet were treated with an antagonist of miR-33 for 4 weeks, resulting in reversed ABCA1 in the liver and plaque macrophages, improved plasma HDL level, and reduced lesion burden (76). This evidence concerns the gene ABCA1 and atherosclerosis.